

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.13117745 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.84750156 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.50033043 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.39630118 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.03744226 |
| 6 | layer formation in cerebral cortex (GO:0021819) | 4.95846681 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.78758154 |
| 8 | glutamate secretion (GO:0014047) | 4.76720659 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.76276102 |
| 10 | vocalization behavior (GO:0071625) | 4.62449468 |
| 11 | proline transport (GO:0015824) | 4.62079691 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.52887845 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.35277607 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24939241 |
| 15 | exploration behavior (GO:0035640) | 4.21709852 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.18484787 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.16318116 |
| 18 | protein localization to synapse (GO:0035418) | 4.13011723 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.03906399 |
| 20 | sodium ion export (GO:0071436) | 4.01478396 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.94563562 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 3.90166354 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 3.83227640 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 3.78873125 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.70048031 |
| 26 | activation of protein kinase A activity (GO:0034199) | 3.69498329 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.67503196 |
| 28 | dendritic spine morphogenesis (GO:0060997) | 3.62626932 |
| 29 | dendrite morphogenesis (GO:0048813) | 3.61934264 |
| 30 | regulation of ARF protein signal transduction (GO:0032012) | 3.60165858 |
| 31 | synaptic vesicle endocytosis (GO:0048488) | 3.59060015 |
| 32 | neuromuscular process controlling balance (GO:0050885) | 3.54389186 |
| 33 | neuronal action potential propagation (GO:0019227) | 3.53552912 |
| 34 | cell migration in hindbrain (GO:0021535) | 3.49067779 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 3.42545381 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.37685053 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.37321913 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.36526979 |
| 39 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.32282909 |
| 40 | long-term memory (GO:0007616) | 3.32016380 |
| 41 | neurotransmitter transport (GO:0006836) | 3.30046477 |
| 42 | clathrin coat assembly (GO:0048268) | 3.25367391 |
| 43 | response to auditory stimulus (GO:0010996) | 3.24979394 |
| 44 | protein localization to endosome (GO:0036010) | 3.24153983 |
| 45 | vesicle transport along microtubule (GO:0047496) | 3.19071940 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.18536805 |
| 47 | neuron recognition (GO:0008038) | 3.18152812 |
| 48 | neuromuscular process controlling posture (GO:0050884) | 3.12458132 |
| 49 | glycine transport (GO:0015816) | 3.09676361 |
| 50 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.08950134 |
| 51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.08846496 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.08268511 |
| 53 | axonal fasciculation (GO:0007413) | 3.08021375 |
| 54 | cell communication by electrical coupling (GO:0010644) | 3.07104636 |
| 55 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.05911675 |
| 56 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.05613696 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04443432 |
| 58 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.04123517 |
| 59 | neuron-neuron synaptic transmission (GO:0007270) | 3.02431930 |
| 60 | regulation of neurotransmitter levels (GO:0001505) | 3.01484628 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00879484 |
| 62 | positive regulation of membrane potential (GO:0045838) | 3.00695591 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00587796 |
| 64 | alanine transport (GO:0032328) | 2.98760409 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.98690206 |
| 66 | axon cargo transport (GO:0008088) | 2.98583070 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 2.96597083 |
| 68 | innervation (GO:0060384) | 2.94479481 |
| 69 | organelle transport along microtubule (GO:0072384) | 2.94300661 |
| 70 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.94073331 |
| 71 | ear development (GO:0043583) | 2.92571333 |
| 72 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.90776549 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 2.90570204 |
| 74 | vagina development (GO:0060068) | 2.90023994 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 2.86187870 |
| 76 | membrane depolarization during action potential (GO:0086010) | 2.85834927 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.85613899 |
| 78 | regulation of vesicle fusion (GO:0031338) | 2.83555039 |
| 79 | transmission of nerve impulse (GO:0019226) | 2.83216395 |
| 80 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.82856098 |
| 81 | cerebellar Purkinje cell layer development (GO:0021680) | 2.82418353 |
| 82 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82241371 |
| 83 | auditory behavior (GO:0031223) | 2.80496499 |
| 84 | neuromuscular process (GO:0050905) | 2.79054028 |
| 85 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.78280027 |
| 86 | prepulse inhibition (GO:0060134) | 2.78139590 |
| 87 | nerve growth factor signaling pathway (GO:0038180) | 2.77972294 |
| 88 | semaphorin-plexin signaling pathway (GO:0071526) | 2.76698651 |
| 89 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.75357356 |
| 90 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.74789411 |
| 91 | regulation of neurotransmitter transport (GO:0051588) | 2.74646984 |
| 92 | potassium ion import (GO:0010107) | 2.74517193 |
| 93 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.70452790 |
| 94 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69950971 |
| 95 | mating behavior (GO:0007617) | 2.69434382 |
| 96 | synapse assembly (GO:0007416) | 2.69082746 |
| 97 | membrane depolarization (GO:0051899) | 2.69049425 |
| 98 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68904751 |
| 99 | negative regulation of fatty acid transport (GO:2000192) | 2.68385038 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.67858301 |
| 101 | establishment of nucleus localization (GO:0040023) | 2.66894218 |
| 102 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.65393355 |
| 103 | adult walking behavior (GO:0007628) | 2.64654532 |
| 104 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.63880778 |
| 105 | social behavior (GO:0035176) | 2.63495738 |
| 106 | intraspecies interaction between organisms (GO:0051703) | 2.63495738 |
| 107 | negative regulation of microtubule polymerization (GO:0031115) | 2.62861348 |
| 108 | response to pheromone (GO:0019236) | 2.62385009 |
| 109 | postsynaptic membrane organization (GO:0001941) | 2.61434650 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.61247591 |
| 111 | cellular sodium ion homeostasis (GO:0006883) | 2.60029126 |
| 112 | regulation of ARF GTPase activity (GO:0032312) | 2.59124357 |
| 113 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.56112912 |
| 114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55274951 |
| 115 | negative regulation of focal adhesion assembly (GO:0051895) | 2.51324269 |
| 116 | negative regulation of cell junction assembly (GO:1901889) | 2.51324269 |
| 117 | negative regulation of adherens junction organization (GO:1903392) | 2.51324269 |
| 118 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.49122105 |
| 119 | uterus development (GO:0060065) | 2.47760037 |
| 120 | macroautophagy (GO:0016236) | 2.46420107 |
| 121 | cell adhesion mediated by integrin (GO:0033627) | 2.44007727 |
| 122 | cell-cell junction maintenance (GO:0045217) | 2.37444680 |
| 123 | COPI coating of Golgi vesicle (GO:0048205) | 2.37017526 |
| 124 | Golgi transport vesicle coating (GO:0048200) | 2.37017526 |
| 125 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.27974883 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27037589 |
| 127 | endothelial cell chemotaxis (GO:0035767) | 2.23988639 |
| 128 | interferon-gamma secretion (GO:0072643) | 2.23386994 |
| 129 | maternal placenta development (GO:0001893) | 2.22544934 |
| 130 | positive regulation of receptor recycling (GO:0001921) | 2.21497581 |
| 131 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.20768870 |
| 132 | epithelial cell-cell adhesion (GO:0090136) | 2.18573796 |
| 133 | intestinal epithelial cell development (GO:0060576) | 2.17681838 |
| 134 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17117791 |
| 135 | barbed-end actin filament capping (GO:0051016) | 2.17096706 |
| 136 | regulation of early endosome to late endosome transport (GO:2000641) | 2.15740919 |
| 137 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.15556668 |
| 138 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.13767148 |
| 139 | glomerular basement membrane development (GO:0032836) | 2.13519127 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.10598491 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.10597008 |
| 142 | regulation of establishment of cell polarity (GO:2000114) | 2.09949302 |
| 143 | response to peptidoglycan (GO:0032494) | 2.09525101 |
| 144 | Rap protein signal transduction (GO:0032486) | 2.07260196 |
| 145 | endocytic recycling (GO:0032456) | 2.06601114 |
| 146 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.05420158 |
| 147 | cellular response to interferon-alpha (GO:0035457) | 2.04775424 |
| 148 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.04714602 |
| 149 | response to laminar fluid shear stress (GO:0034616) | 2.04252580 |
| 150 | amyloid precursor protein catabolic process (GO:0042987) | 2.04197763 |
| 151 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.03866555 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.03695231 |
| 153 | surfactant homeostasis (GO:0043129) | 2.03643620 |
| 154 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.02469451 |
| 155 | female genitalia development (GO:0030540) | 2.02108143 |
| 156 | mannose metabolic process (GO:0006013) | 2.01834017 |
| 157 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 1.99697751 |
| 158 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 1.98844429 |
| 159 | positive regulation of monooxygenase activity (GO:0032770) | 1.98743350 |
| 160 | apical protein localization (GO:0045176) | 1.98682774 |
| 161 | adherens junction assembly (GO:0034333) | 1.97716982 |
| 162 | negative regulation of organic acid transport (GO:0032891) | 1.96516410 |
| 163 | positive regulation of neurotransmitter secretion (GO:0001956) | 1.95699626 |
| 164 | dopamine receptor signaling pathway (GO:0007212) | 1.95511263 |
| 165 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.95360279 |
| 166 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.94538888 |
| 167 | activation of MAPKKK activity (GO:0000185) | 1.94212026 |
| 168 | cell junction maintenance (GO:0034331) | 1.93592820 |
| 169 | wound healing, spreading of epidermal cells (GO:0035313) | 1.93018628 |
| 170 | regulation of NFAT protein import into nucleus (GO:0051532) | 1.92281199 |
| 171 | positive regulation of cholesterol efflux (GO:0010875) | 1.92203816 |
| 172 | embryonic camera-type eye morphogenesis (GO:0048596) | 1.91961605 |
| 173 | striated muscle atrophy (GO:0014891) | 1.90651002 |
| 174 | response to manganese ion (GO:0010042) | 1.90325494 |
| 175 | positive regulation of smooth muscle cell migration (GO:0014911) | 1.90255595 |
| 176 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 1.90181569 |
| 177 | response to nerve growth factor (GO:1990089) | 1.90122123 |
| 178 | cellular response to nerve growth factor stimulus (GO:1990090) | 1.90122123 |
| 179 | apoptotic cell clearance (GO:0043277) | 1.88832135 |
| 180 | response to water (GO:0009415) | 1.88393626 |
| 181 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 1.88250712 |
| 182 | regulation of cholesterol storage (GO:0010885) | 1.88118666 |
| 183 | response to fluid shear stress (GO:0034405) | 1.88065479 |
| 184 | stress fiber assembly (GO:0043149) | 1.87800106 |
| 185 | positive regulation of steroid biosynthetic process (GO:0010893) | 1.87219228 |
| 186 | skeletal muscle adaptation (GO:0043501) | 1.87189612 |
| 187 | endocrine hormone secretion (GO:0060986) | 1.86835620 |
| 188 | regulation of lipid kinase activity (GO:0043550) | 1.86137844 |
| 189 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.85998587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.79668930 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.28720267 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.09775202 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.66801949 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66471871 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.61218782 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60329960 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56811976 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54514981 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41730024 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41730024 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.37905602 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.35973533 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33785528 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33733064 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32561938 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.31137010 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.27966981 |
| 19 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.17702511 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.13364934 |
| 21 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12034659 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.06653637 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05628296 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03993260 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03105324 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00787264 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.96789794 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93207226 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86793724 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.86265547 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.76580488 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74314918 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.69433867 |
| 34 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.67041048 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66662918 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66139908 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62516455 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62422064 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62065740 |
| 40 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56989448 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53680565 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50857383 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42363740 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42022059 |
| 45 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.40824761 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40701705 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39269299 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36466090 |
| 49 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35809119 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.34772951 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33585128 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33200921 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33066274 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32141152 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31737570 |
| 56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31573865 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30937103 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30802535 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29924653 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29790885 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29226877 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28666148 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.27954782 |
| 64 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27877901 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27480488 |
| 66 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27068724 |
| 67 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24421546 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24328842 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23831079 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23510166 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23159834 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21957360 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21617791 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21493498 |
| 75 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.20830086 |
| 76 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20323552 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20042979 |
| 78 | * AR_19668381_ChIP-Seq_PC3_Human | 1.18248507 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17753190 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17674877 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17420375 |
| 82 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17360996 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17027079 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16571573 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13850303 |
| 86 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11062467 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10701405 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06774075 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06690161 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05132147 |
| 91 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05070317 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04709208 |
| 93 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04393417 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03456813 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03426666 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03181774 |
| 97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02566116 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.02564551 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01449635 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01104275 |
| 101 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00365168 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00059172 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99177061 |
| 104 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98845377 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98689961 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97669860 |
| 107 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97459181 |
| 108 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97459181 |
| 109 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97156557 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96548477 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96476099 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96444055 |
| 113 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96080993 |
| 114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95867792 |
| 115 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.95693403 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94297906 |
| 117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93975163 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93898500 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93417350 |
| 120 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92714300 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91679596 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90113489 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90011966 |
| 124 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89753640 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89634989 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89512386 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89053105 |
| 128 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88482564 |
| 129 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87961095 |
| 130 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87850021 |
| 131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87269810 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87229339 |
| 133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87205289 |
| 134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87205289 |
| 135 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87149908 |
| 136 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86959452 |
| 137 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.86842623 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86607227 |
| 139 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86232408 |
| 140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85452588 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85139376 |
| 142 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84070676 |
| 143 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83298792 |
| 144 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.82589749 |
| 145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81742148 |
| 146 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81683334 |
| 147 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81381220 |
| 148 | P300_19829295_ChIP-Seq_ESCs_Human | 0.80706169 |
| 149 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80265510 |
| 150 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79169773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.54272651 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.94329433 |
| 3 | MP0004270_analgesia | 3.79526103 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.49835471 |
| 5 | MP0003880_abnormal_central_pattern | 3.30830641 |
| 6 | MP0009046_muscle_twitch | 3.28129602 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.07762852 |
| 8 | MP0002064_seizures | 2.95753458 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.95129910 |
| 10 | MP0009745_abnormal_behavioral_response | 2.92334160 |
| 11 | MP0004858_abnormal_nervous_system | 2.87752725 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.87167380 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.87160967 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.76577922 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.75310347 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.50033119 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.44254536 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.36186784 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.25956839 |
| 20 | MP0002736_abnormal_nociception_after | 2.17076905 |
| 21 | MP0001486_abnormal_startle_reflex | 2.15315948 |
| 22 | MP0009840_abnormal_foam_cell | 2.15286842 |
| 23 | MP0002272_abnormal_nervous_system | 2.12617850 |
| 24 | MP0001970_abnormal_pain_threshold | 2.10294523 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.09830794 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.08872690 |
| 27 | MP0003091_abnormal_cell_migration | 2.06066698 |
| 28 | MP0004811_abnormal_neuron_physiology | 2.03744180 |
| 29 | MP0002909_abnormal_adrenal_gland | 2.02628793 |
| 30 | MP0005409_darkened_coat_color | 2.01521451 |
| 31 | MP0003329_amyloid_beta_deposits | 2.01092426 |
| 32 | MP0002184_abnormal_innervation | 2.00013598 |
| 33 | MP0000778_abnormal_nervous_system | 1.97346609 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.95158603 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.93692080 |
| 36 | MP0008569_lethality_at_weaning | 1.91299570 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.90541606 |
| 38 | MP0004510_myositis | 1.89678413 |
| 39 | MP0005257_abnormal_intraocular_pressure | 1.89590961 |
| 40 | MP0005248_abnormal_Harderian_gland | 1.87367595 |
| 41 | MP0003303_peritoneal_inflammation | 1.87070083 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.82279610 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.80690923 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.70841683 |
| 45 | MP0000955_abnormal_spinal_cord | 1.69640310 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.69106119 |
| 47 | MP0003879_abnormal_hair_cell | 1.63277530 |
| 48 | MP0002896_abnormal_bone_mineralization | 1.60973732 |
| 49 | MP0001849_ear_inflammation | 1.56436711 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.55342185 |
| 51 | MP0004924_abnormal_behavior | 1.55342185 |
| 52 | MP0004885_abnormal_endolymph | 1.55036738 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.53821145 |
| 54 | MP0010678_abnormal_skin_adnexa | 1.50570470 |
| 55 | MP0002796_impaired_skin_barrier | 1.49419275 |
| 56 | MP0001958_emphysema | 1.48281448 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.47776647 |
| 58 | MP0003633_abnormal_nervous_system | 1.46300437 |
| 59 | MP0000604_amyloidosis | 1.45419428 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.45131454 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.43878982 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.42661791 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.37761810 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.35672521 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.35447101 |
| 66 | MP0005451_abnormal_body_composition | 1.35113033 |
| 67 | MP0000383_abnormal_hair_follicle | 1.34777652 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.34335193 |
| 69 | MP0003123_paternal_imprinting | 1.32076287 |
| 70 | MP0008260_abnormal_autophagy | 1.30689027 |
| 71 | MP0006082_CNS_inflammation | 1.29748777 |
| 72 | MP0003279_aneurysm | 1.29331122 |
| 73 | MP0003690_abnormal_glial_cell | 1.29177136 |
| 74 | MP0003075_altered_response_to | 1.27634508 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.24357939 |
| 76 | MP0003634_abnormal_glial_cell | 1.22341346 |
| 77 | MP0001502_abnormal_circadian_rhythm | 1.21398775 |
| 78 | MP0003631_nervous_system_phenotype | 1.18495221 |
| 79 | MP0003724_increased_susceptibility_to | 1.17194765 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.14391281 |
| 81 | MP0002822_catalepsy | 1.12882396 |
| 82 | MP0003787_abnormal_imprinting | 1.12426557 |
| 83 | MP0002152_abnormal_brain_morphology | 1.11954898 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.11115038 |
| 85 | MP0009384_cardiac_valve_regurgitation | 1.09420678 |
| 86 | MP0005275_abnormal_skin_tensile | 1.08466307 |
| 87 | MP0001533_abnormal_skeleton_physiology | 1.08413451 |
| 88 | MP0002229_neurodegeneration | 1.06232502 |
| 89 | MP0003828_pulmonary_edema | 1.05242024 |
| 90 | MP0005058_abnormal_lysosome_morphology | 1.04703968 |
| 91 | MP0001542_abnormal_bone_strength | 1.03841364 |
| 92 | MP0001984_abnormal_olfaction | 1.02502783 |
| 93 | MP0000462_abnormal_digestive_system | 1.01341768 |
| 94 | MP0004883_abnormal_blood_vessel | 0.99877129 |
| 95 | MP0000343_altered_response_to | 0.98866905 |
| 96 | MP0002090_abnormal_vision | 0.98729123 |
| 97 | MP0003283_abnormal_digestive_organ | 0.98384961 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.97766690 |
| 99 | MP0004947_skin_inflammation | 0.97511974 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.96052418 |
| 101 | MP0004381_abnormal_hair_follicle | 0.95583072 |
| 102 | MP0003632_abnormal_nervous_system | 0.93634736 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.92827047 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 0.90944830 |
| 105 | MP0004272_abnormal_basement_membrane | 0.90165469 |
| 106 | MP0004142_abnormal_muscle_tone | 0.89807625 |
| 107 | MP0004742_abnormal_vestibular_system | 0.89778388 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.88090999 |
| 109 | MP0009115_abnormal_fat_cell | 0.87506111 |
| 110 | MP0008004_abnormal_stomach_pH | 0.87389597 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.87305996 |
| 112 | MP0002098_abnormal_vibrissa_morphology | 0.86818640 |
| 113 | MP0005535_abnormal_body_temperature | 0.86802871 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.86106249 |
| 115 | MP0005164_abnormal_response_to | 0.83591722 |
| 116 | MP0003436_decreased_susceptibility_to | 0.83231717 |
| 117 | MP0000627_abnormal_mammary_gland | 0.83046174 |
| 118 | MP0008874_decreased_physiological_sensi | 0.82766211 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.81583309 |
| 120 | MP0001299_abnormal_eye_distance/ | 0.78929817 |
| 121 | MP0003045_fibrosis | 0.77723908 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.75281469 |
| 123 | MP0002419_abnormal_innate_immunity | 0.73312369 |
| 124 | MP0000858_altered_metastatic_potential | 0.73269522 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.72084969 |
| 126 | MP0000371_diluted_coat_color | 0.71633257 |
| 127 | MP0000920_abnormal_myelination | 0.71523776 |
| 128 | MP0005166_decreased_susceptibility_to | 0.70922726 |
| 129 | MP0008872_abnormal_physiological_respon | 0.70265241 |
| 130 | MP0005646_abnormal_pituitary_gland | 0.69753371 |
| 131 | MP0002971_abnormal_brown_adipose | 0.69750314 |
| 132 | MP0005499_abnormal_olfactory_system | 0.69108129 |
| 133 | MP0005394_taste/olfaction_phenotype | 0.69108129 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.68976108 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.68206363 |
| 136 | MP0001963_abnormal_hearing_physiology | 0.66251066 |
| 137 | MP0002653_abnormal_ependyma_morphology | 0.65999138 |
| 138 | MP0004130_abnormal_muscle_cell | 0.65764785 |
| 139 | MP0002752_abnormal_somatic_nervous | 0.65386889 |
| 140 | MP0003868_abnormal_feces_composition | 0.64526982 |
| 141 | MP0001177_atelectasis | 0.64308760 |
| 142 | MP0002168_other_aberrant_phenotype | 0.64124116 |
| 143 | MP0003942_abnormal_urinary_system | 0.64062300 |
| 144 | MP0003122_maternal_imprinting | 0.63557066 |
| 145 | MP0005076_abnormal_cell_differentiation | 0.63510144 |
| 146 | MP0005187_abnormal_penis_morphology | 0.63052361 |
| 147 | MP0009785_altered_susceptibility_to | 0.63038236 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.61468897 |
| 149 | MP0002133_abnormal_respiratory_system | 0.60475737 |
| 150 | MP0005388_respiratory_system_phenotype | 0.60475737 |
| 151 | MP0003861_abnormal_nervous_system | 0.58104690 |
| 152 | MP0005551_abnormal_eye_electrophysiolog | 0.57321410 |
| 153 | MP0005310_abnormal_salivary_gland | 0.56882446 |
| 154 | MP0000013_abnormal_adipose_tissue | 0.56302546 |
| 155 | MP0004085_abnormal_heartbeat | 0.55711616 |
| 156 | MP0004233_abnormal_muscle_weight | 0.55314606 |
| 157 | MP0001905_abnormal_dopamine_level | 0.52183362 |
| 158 | MP0004484_altered_response_of | 0.51285830 |
| 159 | MP0010769_abnormal_survival | 0.50850069 |
| 160 | MP0002082_postnatal_lethality | 0.48151421 |
| 161 | MP0010770_preweaning_lethality | 0.48151421 |
| 162 | MP0010768_mortality/aging | 0.46000432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.51974226 |
| 2 | Visual hallucinations (HP:0002367) | 5.16871301 |
| 3 | Focal motor seizures (HP:0011153) | 4.96645722 |
| 4 | Mutism (HP:0002300) | 4.77270283 |
| 5 | Focal seizures (HP:0007359) | 4.64282414 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.48254690 |
| 7 | Action tremor (HP:0002345) | 4.28478041 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.06102055 |
| 9 | J-shaped sella turcica (HP:0002680) | 3.94543619 |
| 10 | Absent frontal sinuses (HP:0002688) | 3.63405804 |
| 11 | Papilledema (HP:0001085) | 3.45150784 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.44118741 |
| 13 | Febrile seizures (HP:0002373) | 3.41220541 |
| 14 | Atonic seizures (HP:0010819) | 3.39448375 |
| 15 | Absence seizures (HP:0002121) | 3.27182446 |
| 16 | Ankle clonus (HP:0011448) | 3.27164789 |
| 17 | Asymmetry of the thorax (HP:0001555) | 3.09190409 |
| 18 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.08526158 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.05455705 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.05455705 |
| 21 | Thin bony cortex (HP:0002753) | 3.04888578 |
| 22 | Postural instability (HP:0002172) | 2.98487696 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 2.97493431 |
| 24 | Dialeptic seizures (HP:0011146) | 2.97477751 |
| 25 | Cerebral aneurysm (HP:0004944) | 2.95393065 |
| 26 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.94477440 |
| 27 | Genetic anticipation (HP:0003743) | 2.93537268 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.89008937 |
| 29 | Depression (HP:0000716) | 2.88073976 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86651100 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86651100 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86651100 |
| 33 | Amyotrophic lateral sclerosis (HP:0007354) | 2.82880286 |
| 34 | Truncal ataxia (HP:0002078) | 2.80756568 |
| 35 | Diplopia (HP:0000651) | 2.79881921 |
| 36 | Abnormality of binocular vision (HP:0011514) | 2.79881921 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.79342708 |
| 38 | Deformed sella turcica (HP:0002681) | 2.77977086 |
| 39 | Inappropriate behavior (HP:0000719) | 2.76540518 |
| 40 | Apathy (HP:0000741) | 2.75279924 |
| 41 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.72052281 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.71298615 |
| 43 | Testicular neoplasm (HP:0010788) | 2.70158834 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.66960071 |
| 45 | Poor eye contact (HP:0000817) | 2.64988706 |
| 46 | Hemiparesis (HP:0001269) | 2.64371214 |
| 47 | Arterial tortuosity (HP:0005116) | 2.64028391 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.62506673 |
| 49 | Hemiplegia (HP:0002301) | 2.61831024 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.59189644 |
| 51 | Broad-based gait (HP:0002136) | 2.58148577 |
| 52 | Gaze-evoked nystagmus (HP:0000640) | 2.57287283 |
| 53 | Impaired social interactions (HP:0000735) | 2.56717422 |
| 54 | Abnormal social behavior (HP:0012433) | 2.56717422 |
| 55 | Drooling (HP:0002307) | 2.55315745 |
| 56 | Excessive salivation (HP:0003781) | 2.55315745 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.55242672 |
| 58 | Intention tremor (HP:0002080) | 2.53513638 |
| 59 | Agitation (HP:0000713) | 2.52897250 |
| 60 | Esophageal varix (HP:0002040) | 2.50187632 |
| 61 | Impaired smooth pursuit (HP:0007772) | 2.49733945 |
| 62 | Dysdiadochokinesis (HP:0002075) | 2.48583259 |
| 63 | Diminished motivation (HP:0000745) | 2.47535512 |
| 64 | Long toe (HP:0010511) | 2.46827575 |
| 65 | Dysmetria (HP:0001310) | 2.46266982 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.46251733 |
| 67 | Cervical subluxation (HP:0003308) | 2.45004179 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.43707250 |
| 69 | Loss of speech (HP:0002371) | 2.43357780 |
| 70 | Hyperparathyroidism (HP:0000843) | 2.42037606 |
| 71 | Urinary urgency (HP:0000012) | 2.41320147 |
| 72 | Vascular tortuosity (HP:0004948) | 2.40545996 |
| 73 | Progressive inability to walk (HP:0002505) | 2.39798809 |
| 74 | Disinhibition (HP:0000734) | 2.39265566 |
| 75 | Ventricular fibrillation (HP:0001663) | 2.39120929 |
| 76 | Protrusio acetabuli (HP:0003179) | 2.38207089 |
| 77 | Nuclear cataract (HP:0100018) | 2.38179855 |
| 78 | Germ cell neoplasia (HP:0100728) | 2.38044151 |
| 79 | Termporal pattern (HP:0011008) | 2.35887936 |
| 80 | Insidious onset (HP:0003587) | 2.35887936 |
| 81 | Abnormality of the frontal sinuses (HP:0002687) | 2.34919537 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33347775 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33347775 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33347775 |
| 85 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.31252202 |
| 86 | Broad face (HP:0000283) | 2.25592868 |
| 87 | Akinesia (HP:0002304) | 2.23658252 |
| 88 | Glomerulonephritis (HP:0000099) | 2.23189893 |
| 89 | Obstructive sleep apnea (HP:0002870) | 2.22083610 |
| 90 | Stereotypic behavior (HP:0000733) | 2.20730493 |
| 91 | Spastic gait (HP:0002064) | 2.20694354 |
| 92 | Flat acetabular roof (HP:0003180) | 2.20126030 |
| 93 | Syringomyelia (HP:0003396) | 2.17601387 |
| 94 | Spinal cord lesions (HP:0100561) | 2.17601387 |
| 95 | Amblyopia (HP:0000646) | 2.15442579 |
| 96 | Mitral stenosis (HP:0001718) | 2.15274772 |
| 97 | Pointed chin (HP:0000307) | 2.15036429 |
| 98 | Limb dystonia (HP:0002451) | 2.14807941 |
| 99 | Insomnia (HP:0100785) | 2.12806608 |
| 100 | Megalencephaly (HP:0001355) | 2.12486425 |
| 101 | Bradykinesia (HP:0002067) | 2.12469575 |
| 102 | Failure to thrive in infancy (HP:0001531) | 2.12074020 |
| 103 | Macroorchidism (HP:0000053) | 2.10861822 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 2.10857289 |
| 105 | Polyphagia (HP:0002591) | 2.09535152 |
| 106 | Micronodular cirrhosis (HP:0001413) | 2.08638634 |
| 107 | Torticollis (HP:0000473) | 2.05883315 |
| 108 | Axonal loss (HP:0003447) | 2.05576847 |
| 109 | Rapidly progressive (HP:0003678) | 2.04839741 |
| 110 | Aqueductal stenosis (HP:0002410) | 2.04729203 |
| 111 | Annular pancreas (HP:0001734) | 2.02115878 |
| 112 | Abnormality of the sella turcica (HP:0002679) | 2.01462625 |
| 113 | Vertebral compression fractures (HP:0002953) | 2.01365037 |
| 114 | Anxiety (HP:0000739) | 2.00353971 |
| 115 | Lower limb asymmetry (HP:0100559) | 2.00052105 |
| 116 | Buphthalmos (HP:0000557) | 1.99240628 |
| 117 | Short nail (HP:0001799) | 1.99201521 |
| 118 | Lower limb muscle weakness (HP:0007340) | 1.98821300 |
| 119 | Dysmetric saccades (HP:0000641) | 1.98619654 |
| 120 | Postural tremor (HP:0002174) | 1.97346496 |
| 121 | Status epilepticus (HP:0002133) | 1.93654439 |
| 122 | Bundle branch block (HP:0011710) | 1.93187421 |
| 123 | Hyperacusis (HP:0010780) | 1.91734803 |
| 124 | Premature rupture of membranes (HP:0001788) | 1.88923181 |
| 125 | Pheochromocytoma (HP:0002666) | 1.88272031 |
| 126 | Abnormality of macrophages (HP:0004311) | 1.87808120 |
| 127 | Hand muscle atrophy (HP:0009130) | 1.87520815 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.87408625 |
| 129 | Fetal akinesia sequence (HP:0001989) | 1.87242408 |
| 130 | Hypercortisolism (HP:0001578) | 1.84267489 |
| 131 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83882760 |
| 132 | Vacuolated lymphocytes (HP:0001922) | 1.83673769 |
| 133 | Scanning speech (HP:0002168) | 1.83169065 |
| 134 | Abnormality of the periventricular white matter (HP:0002518) | 1.81477671 |
| 135 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81074359 |
| 136 | Hypsarrhythmia (HP:0002521) | 1.81028451 |
| 137 | Dementia (HP:0000726) | 1.80994372 |
| 138 | Epileptiform EEG discharges (HP:0011182) | 1.80955330 |
| 139 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78773024 |
| 140 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78492202 |
| 141 | Sparse lateral eyebrow (HP:0005338) | 1.77902128 |
| 142 | Dysostosis multiplex (HP:0000943) | 1.77385837 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.76672954 |
| 144 | Bone pain (HP:0002653) | 1.76651198 |
| 145 | Focal dystonia (HP:0004373) | 1.76631835 |
| 146 | Congenital glaucoma (HP:0001087) | 1.75855511 |
| 147 | Rigidity (HP:0002063) | 1.75837247 |
| 148 | Absent speech (HP:0001344) | 1.75493290 |
| 149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74397604 |
| 150 | Osteolytic defects of the hand bones (HP:0009699) | 1.74397604 |
| 151 | Amyloidosis (HP:0011034) | 1.74063753 |
| 152 | Abdominal distention (HP:0003270) | 1.73220619 |
| 153 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73157910 |
| 154 | Aneurysm (HP:0002617) | 1.71204939 |
| 155 | Aortic dissection (HP:0002647) | 1.70860549 |
| 156 | Systemic lupus erythematosus (HP:0002725) | 1.70829891 |
| 157 | Myocardial infarction (HP:0001658) | 1.68697692 |
| 158 | Mitral regurgitation (HP:0001653) | 1.68295000 |
| 159 | Spinal cord compression (HP:0002176) | 1.68153753 |
| 160 | Spondylolisthesis (HP:0003302) | 1.64666239 |
| 161 | Mitral valve prolapse (HP:0001634) | 1.63855783 |
| 162 | Malnutrition (HP:0004395) | 1.59679856 |
| 163 | Eczematoid dermatitis (HP:0000976) | 1.59312646 |
| 164 | Distal lower limb muscle weakness (HP:0009053) | 1.58615197 |
| 165 | Distal upper limb amyotrophy (HP:0007149) | 1.57129409 |
| 166 | Upper limb amyotrophy (HP:0009129) | 1.57129409 |
| 167 | Lymphangioma (HP:0100764) | 1.56550352 |
| 168 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.56505389 |
| 169 | Deep venous thrombosis (HP:0002625) | 1.56088870 |
| 170 | Enlarged penis (HP:0000040) | 1.56067297 |
| 171 | Urinary incontinence (HP:0000020) | 1.55793638 |
| 172 | Overgrowth (HP:0001548) | 1.55078254 |
| 173 | Pathologic fracture (HP:0002756) | 1.54749038 |
| 174 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.53731566 |
| 175 | Visceral angiomatosis (HP:0100761) | 1.53462995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.75984150 |
| 2 | MARK1 | 4.59455053 |
| 3 | NTRK3 | 3.50940747 |
| 4 | SIK1 | 2.89092876 |
| 5 | MINK1 | 2.71397201 |
| 6 | MAP3K4 | 2.68212425 |
| 7 | PAK6 | 2.56383755 |
| 8 | DAPK2 | 2.44982320 |
| 9 | IRAK3 | 2.41357506 |
| 10 | KSR2 | 2.30219678 |
| 11 | CAMKK1 | 2.29569863 |
| 12 | RIPK4 | 2.22167739 |
| 13 | NTRK2 | 2.17152323 |
| 14 | NTRK1 | 2.05568516 |
| 15 | MAP2K7 | 1.83890575 |
| 16 | EPHA4 | 1.81310909 |
| 17 | PIK3CA | 1.81235360 |
| 18 | SIK2 | 1.76664702 |
| 19 | PRKD3 | 1.74361917 |
| 20 | MAP2K4 | 1.65063831 |
| 21 | NEK6 | 1.61998374 |
| 22 | RIPK1 | 1.58805943 |
| 23 | LATS2 | 1.57207093 |
| 24 | GRK5 | 1.55851600 |
| 25 | TAOK1 | 1.54179695 |
| 26 | CAMKK2 | 1.51181980 |
| 27 | TESK1 | 1.51114731 |
| 28 | MAP3K2 | 1.49346060 |
| 29 | CDK5 | 1.46857607 |
| 30 | STK38 | 1.46456607 |
| 31 | FGFR4 | 1.46008752 |
| 32 | KSR1 | 1.45379973 |
| 33 | PHKG2 | 1.42259624 |
| 34 | PHKG1 | 1.42259624 |
| 35 | ERN1 | 1.41683936 |
| 36 | SCYL2 | 1.37499526 |
| 37 | ALK | 1.35948744 |
| 38 | CHUK | 1.35413559 |
| 39 | RET | 1.31255878 |
| 40 | SIK3 | 1.25841906 |
| 41 | TYRO3 | 1.19760255 |
| 42 | CAMK1G | 1.19058589 |
| 43 | EPHA2 | 1.16844123 |
| 44 | PNCK | 1.15800547 |
| 45 | DAPK1 | 1.14026125 |
| 46 | STK11 | 1.13019352 |
| 47 | IKBKE | 1.08146324 |
| 48 | MAPK13 | 1.07928004 |
| 49 | MAP3K14 | 1.05877389 |
| 50 | MAP3K12 | 1.04529392 |
| 51 | EEF2K | 1.01239208 |
| 52 | BMPR2 | 1.00615991 |
| 53 | PLK2 | 0.98938971 |
| 54 | MAP3K13 | 0.97537404 |
| 55 | FES | 0.96789035 |
| 56 | TBK1 | 0.96283471 |
| 57 | CSNK1G2 | 0.96102646 |
| 58 | TTN | 0.95314446 |
| 59 | PRKCG | 0.94209625 |
| 60 | PAK4 | 0.93032142 |
| 61 | BLK | 0.92668626 |
| 62 | TGFBR2 | 0.92135365 |
| 63 | LMTK2 | 0.91344762 |
| 64 | PRKCH | 0.90384033 |
| 65 | UHMK1 | 0.89554600 |
| 66 | MAP3K3 | 0.89251028 |
| 67 | ARAF | 0.85112528 |
| 68 | NME2 | 0.84950870 |
| 69 | TYK2 | 0.81572003 |
| 70 | IRAK2 | 0.79531935 |
| 71 | PDGFRB | 0.77289622 |
| 72 | PTK2 | 0.77185103 |
| 73 | CSF1R | 0.77117459 |
| 74 | FER | 0.76513306 |
| 75 | MTOR | 0.75053748 |
| 76 | PDK1 | 0.73879608 |
| 77 | CDK15 | 0.73551867 |
| 78 | WNK1 | 0.73346868 |
| 79 | TRIB3 | 0.73306778 |
| 80 | PAK3 | 0.72784780 |
| 81 | MAPKAPK3 | 0.71990989 |
| 82 | CDK14 | 0.71278905 |
| 83 | CDK18 | 0.71259722 |
| 84 | MAP2K2 | 0.71181872 |
| 85 | ICK | 0.71170548 |
| 86 | FGR | 0.70341925 |
| 87 | PRKCZ | 0.70140293 |
| 88 | CDK19 | 0.69987145 |
| 89 | RPS6KA2 | 0.69645650 |
| 90 | RPS6KL1 | 0.69290022 |
| 91 | RPS6KC1 | 0.69290022 |
| 92 | RPS6KB1 | 0.68741248 |
| 93 | CAMK2B | 0.68118003 |
| 94 | SMG1 | 0.66806035 |
| 95 | CSK | 0.65082514 |
| 96 | SGK3 | 0.64979112 |
| 97 | PDPK1 | 0.64762175 |
| 98 | ERBB3 | 0.64729667 |
| 99 | CAMK2A | 0.63307290 |
| 100 | MARK2 | 0.63052352 |
| 101 | DYRK1B | 0.62601000 |
| 102 | CAMK1 | 0.62577148 |
| 103 | SGK1 | 0.62382698 |
| 104 | FGFR3 | 0.61934915 |
| 105 | CDK11A | 0.61479371 |
| 106 | MAPK4 | 0.59172671 |
| 107 | PRKD2 | 0.57996943 |
| 108 | MOS | 0.57933440 |
| 109 | PRKD1 | 0.57300736 |
| 110 | FYN | 0.57284669 |
| 111 | MAP2K1 | 0.57045636 |
| 112 | CASK | 0.56786945 |
| 113 | MATK | 0.55962770 |
| 114 | MAP3K1 | 0.54825562 |
| 115 | JAK1 | 0.53270411 |
| 116 | CAMK1D | 0.53253514 |
| 117 | SGK494 | 0.53018223 |
| 118 | SGK223 | 0.53018223 |
| 119 | DDR2 | 0.52508982 |
| 120 | DYRK1A | 0.52492794 |
| 121 | CDC42BPA | 0.52406205 |
| 122 | PRPF4B | 0.52195575 |
| 123 | MYLK | 0.49995485 |
| 124 | RPS6KA6 | 0.49109906 |
| 125 | TAOK2 | 0.48767665 |
| 126 | ROCK2 | 0.48430071 |
| 127 | RPS6KA3 | 0.45872239 |
| 128 | MAPK10 | 0.45830121 |
| 129 | RAF1 | 0.44778849 |
| 130 | RPS6KB2 | 0.44694392 |
| 131 | SGK2 | 0.44587777 |
| 132 | MAP3K11 | 0.44474342 |
| 133 | CAMK4 | 0.43915023 |
| 134 | JAK2 | 0.42869460 |
| 135 | PKN1 | 0.38561269 |
| 136 | PDGFRA | 0.38153456 |
| 137 | MAP3K6 | 0.37713092 |
| 138 | PKN2 | 0.37394492 |
| 139 | MAPK12 | 0.36977759 |
| 140 | CSNK1G3 | 0.34419874 |
| 141 | BMX | 0.34207150 |
| 142 | PRKCE | 0.33854279 |
| 143 | TNIK | 0.33740490 |
| 144 | CSNK1A1L | 0.33402785 |
| 145 | LIMK1 | 0.32275317 |
| 146 | MAPK8 | 0.30883028 |
| 147 | PTK6 | 0.30125034 |
| 148 | SRC | 0.28786128 |
| 149 | DMPK | 0.28473728 |
| 150 | HIPK2 | 0.28010323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.00360317 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.52337287 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26389069 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.12530125 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12134694 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.10894907 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.08152994 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.03724561 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99861063 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 1.91210564 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.79882438 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72938015 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72785746 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69979970 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68780209 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64889999 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.62875887 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59190370 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.54815427 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51642306 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50611411 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48278716 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.46079422 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43551994 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38304947 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37937988 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.37886765 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36350413 |
| 29 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.34207527 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.34126754 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29226602 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28985301 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28850972 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.25695987 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.25093567 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.23136240 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21569999 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20300630 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18697598 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16396004 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14560070 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11335589 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10696156 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10143663 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09416053 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06761330 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06680792 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.02814596 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.02565718 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02467930 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.00771681 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99901138 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99237906 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.99123707 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.99073455 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98653203 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97124232 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96921595 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96708983 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93872907 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93246688 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91894718 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91268758 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.89697746 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89617650 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88744350 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88622358 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88072067 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88021839 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86597600 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85624682 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.83985642 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83980782 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83289434 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82911715 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81899781 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.81746798 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.81585708 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80695099 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80017114 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.79681410 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77950467 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76908332 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76855428 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.76438932 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75976623 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75357789 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75087611 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74054704 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73978551 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72973190 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70885156 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.70868201 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69307273 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.69092892 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68516764 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.67752066 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.67740618 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67045858 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66828647 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66749862 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.66672261 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66474188 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65562809 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65242394 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63735733 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.63660707 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63590232 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63482700 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63292741 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.62603624 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62083856 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60679126 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60051415 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59714459 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59696069 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59664071 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.59196922 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59140077 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58377283 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56354879 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56192088 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55713016 |
| 124 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55265342 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55201546 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55080525 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54714532 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53160694 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53075922 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49942228 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.49249753 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47744286 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.47623523 |
| 134 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47362914 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47362436 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46881370 |

